Literature DB >> 1303764

A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41.

G Fujii1, S Horvath, S Woodward, F Eiserling, D Eisenberg.   

Abstract

The mechanism of protein-mediated membrane fusion and lysis has been investigated by solution-state studies of the effects of peptides on liposomes. A peptide (SI) corresponding to a highly amphiphilic C-terminal segment from the envelope protein (gp41) of the human immunodeficiency virus (HIV) was synthesized and tested for its ability to cause lipid membranes to fuse together (fusion) or to break open (lysis). These effects were compared to those produced by the lytic and fusogenic peptide from bee venom, melittin. Other properties studied included the changes in visible absorbance and mean particle size, and the secondary structure of peptides as judged by CD spectroscopy. Taken together, the observations suggest that protein-mediated membrane fusion is dependent not only on hydrophobic and electrostatic forces but also on the spatial arrangement of the amino acid residues to form an amphiphilic structure that promotes the mixing of the lipids between membranes. A speculative molecular model is proposed for membrane fusion by alpha-helical peptides, and its relationship to the forces involved in protein-membrane interactions is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1303764      PMCID: PMC2142113          DOI: 10.1002/pro.5560011107

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  41 in total

Review 1.  Membrane fusion of enveloped viruses: especially a matter of proteins.

Authors:  D Hoekstra
Journal:  J Bioenerg Biomembr       Date:  1990-04       Impact factor: 2.945

Review 2.  Viral and cellular membrane fusion proteins.

Authors:  J M White
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

Review 3.  Immunobiology of the human immunodeficiency virus envelope and its relationship to vaccine strategies.

Authors:  D P Bolognesi
Journal:  Mol Biol Med       Date:  1990-02

Review 4.  The actions of melittin on membranes.

Authors:  C E Dempsey
Journal:  Biochim Biophys Acta       Date:  1990-05-07

5.  Incorporation of melittin into phosphatidylcholine bilayers. Study of binding and conformational changes.

Authors:  H Vogel
Journal:  FEBS Lett       Date:  1981-11-02       Impact factor: 4.124

6.  Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity.

Authors:  S J Lee; W Hu; A G Fisher; D J Looney; V F Kao; H Mitsuya; L Ratner; F Wong-Staal
Journal:  AIDS Res Hum Retroviruses       Date:  1989-08       Impact factor: 2.205

7.  Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

Authors:  J S Allan; J E Coligan; F Barin; M F McLane; J G Sodroski; C A Rosen; W A Haseltine; T H Lee; M Essex
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

8.  The interaction of bee melittin with lipid bilayer membranes.

Authors:  C R Dawson; A F Drake; J Helliwell; R C Hider
Journal:  Biochim Biophys Acta       Date:  1978-06-16

9.  Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

Authors:  R L Willey; J S Bonifacino; B J Potts; M A Martin; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

10.  pH-dependent bilayer destabilization by an amphipathic peptide.

Authors:  N K Subbarao; R A Parente; F C Szoka; L Nadasdi; K Pongracz
Journal:  Biochemistry       Date:  1987-06-02       Impact factor: 3.162

View more
  12 in total

1.  Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.

Authors:  S S Chen; S F Lee; C T Wang
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins.

Authors:  S B Tencza; J P Douglass; D J Creighton; R C Montelaro; T A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

3.  Alternative splicing of class Ib major histocompatibility complex transcripts in vivo leads to the expression of soluble Qa-2 molecules in murine blood.

Authors:  P Tabaczewski; H Shirwan; K Lewis; I Stroynowski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

4.  Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane.

Authors:  Mathias Viard; Sherimay D Ablan; Ming Zhou; Timothy D Veenstra; Eric O Freed; Yossef Raviv; Robert Blumenthal
Journal:  Biochemistry       Date:  2008-01-17       Impact factor: 3.162

5.  Topology of the C-terminal tail of HIV-1 gp41: differential exposure of the Kennedy epitope on cell and viral membranes.

Authors:  Jonathan D Steckbeck; Chengqun Sun; Timothy J Sturgeon; Ronald C Montelaro
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

Review 6.  Structural and functional comparisons of retroviral envelope protein C-terminal domains: still much to learn.

Authors:  Jonathan D Steckbeck; Anne-Sophie Kuhlmann; Ronald C Montelaro
Journal:  Viruses       Date:  2014-01-16       Impact factor: 5.048

Review 7.  C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.

Authors:  Jonathan D Steckbeck; Anne-Sophie Kuhlmann; Ronald C Montelaro
Journal:  J Gen Virol       Date:  2012-10-17       Impact factor: 3.891

8.  Detailed topology mapping reveals substantial exposure of the "cytoplasmic" C-terminal tail (CTT) sequences in HIV-1 Env proteins at the cell surface.

Authors:  Jonathan D Steckbeck; Chengqun Sun; Timothy J Sturgeon; Ronald C Montelaro
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

9.  Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein.

Authors:  Joshua M Costin; Joshua M Rausch; Robert F Garry; William C Wimley
Journal:  Virol J       Date:  2007-11-20       Impact factor: 4.099

Review 10.  Cytopathic mechanisms of HIV-1.

Authors:  Joshua M Costin
Journal:  Virol J       Date:  2007-10-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.